451 related articles for article (PubMed ID: 26467459)
1. Evaluation of Oncological Safety of Fat Grafting After Breast-Conserving Therapy: A Prospective Study.
Mestak O; Hromadkova V; Fajfrova M; Molitor M; Mestak J
Ann Surg Oncol; 2016 Mar; 23(3):776-81. PubMed ID: 26467459
[TBL] [Abstract][Full Text] [Related]
2. Oncological safety of breast cancer patients undergoing free-flap reconstruction and lipofilling.
Masia J; Bordoni D; Pons G; Liuzza C; Castagnetti F; Falco G
Eur J Surg Oncol; 2015 May; 41(5):612-6. PubMed ID: 25800344
[TBL] [Abstract][Full Text] [Related]
3. Early experience of immediate reconstruction using autologous free dermal fat graft after breast conservational surgery.
Kijima Y; Yoshinaka H; Owaki T; Aikou T
J Plast Reconstr Aesthet Surg; 2007; 60(5):495-502. PubMed ID: 17399658
[TBL] [Abstract][Full Text] [Related]
4. Breast conservative surgery and local recurrence.
Rezai M; Kraemer S; Kimmig R; Kern P
Breast; 2015 Nov; 24 Suppl 2():S100-7. PubMed ID: 26432359
[TBL] [Abstract][Full Text] [Related]
5. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
[TBL] [Abstract][Full Text] [Related]
6. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
[TBL] [Abstract][Full Text] [Related]
7. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
[TBL] [Abstract][Full Text] [Related]
8. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
Tafra L; Essner R; Brenner RJ; Giuliano AE
Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
[TBL] [Abstract][Full Text] [Related]
9. Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
Ryu JM; Park S; Paik HJ; Nam SJ; Kim SW; Lee SK; Yu J; Bae SY; Kim I; Bang SI; Mun GH; Pyon JK; Jeon BJ; Lee JE
Clin Breast Cancer; 2017 Jun; 17(3):204-210. PubMed ID: 28065399
[TBL] [Abstract][Full Text] [Related]
10. Oncological safety of autologous fat grafting after breast conservative treatment: a prospective evaluation.
Brenelli F; Rietjens M; De Lorenzi F; Pinto-Neto A; Rossetto F; Martella S; Rodrigues JR; Barbalho D
Breast J; 2014; 20(2):159-65. PubMed ID: 24450421
[TBL] [Abstract][Full Text] [Related]
11. Fat Grafting after Invasive Breast Cancer: A Matched Case-Control Study.
Petit JY; Maisonneuve P; Rotmensz N; Bertolini F; Rietjens M
Plast Reconstr Surg; 2017 Jun; 139(6):1292-1296. PubMed ID: 28538546
[TBL] [Abstract][Full Text] [Related]
12. Autologous Fat Grafting After Breast Reconstruction in Postmastectomy Patients: Complications, Biopsy Rates, and Locoregional Cancer Recurrence Rates.
Kaoutzanis C; Xin M; Ballard TN; Welch KB; Momoh AO; Kozlow JH; Brown DL; Cederna PS; Wilkins EG
Ann Plast Surg; 2016 Mar; 76(3):270-5. PubMed ID: 26101979
[TBL] [Abstract][Full Text] [Related]
13. Incidence of occult contralateral carcinomas of the breast following mastoplasty aimed at symmetrization.
Sorin T; Fyad JP; Pujo J; Colson T; Bordes V; Leroux A; Marchal F; Brix M; Simon E; Verhaeghe JL; Classe JM; Dolivet G
Ann Chir Plast Esthet; 2014 Apr; 59(2):e21-8. PubMed ID: 24530086
[TBL] [Abstract][Full Text] [Related]
14. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Residual Tumor in Breast-Conserving Therapy.
Rath MG; Uhlmann L; Heil J; Domschke C; Roth Z; Sinn HP; Marme F; Scharf A; Schneeweiss A; Kieser M; Sohn C; Rom J
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S451-8. PubMed ID: 26224405
[TBL] [Abstract][Full Text] [Related]
16. Oncologic safety of immediate autologous fat grafting for reconstruction in breast-conserving surgery.
Stumpf CC; Zucatto ÂE; Cavalheiro JAC; de Melo MP; Cericato R; Damin APS; Biazús JV
Breast Cancer Res Treat; 2020 Apr; 180(2):301-309. PubMed ID: 32026213
[TBL] [Abstract][Full Text] [Related]
17. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
[TBL] [Abstract][Full Text] [Related]
18. Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 Chinese breast cancer cases.
Li S; Yu KD; Fan L; Hou YF; Shao ZM
Ann Surg Oncol; 2011 Sep; 18(9):2492-9. PubMed ID: 21360247
[TBL] [Abstract][Full Text] [Related]
19. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?
Yerushalmi R; Tyldesley S; Woods R; Kennecke HF; Speers C; Gelmon KA
Ann Oncol; 2012 Apr; 23(4):876-81. PubMed ID: 21810730
[TBL] [Abstract][Full Text] [Related]
20. The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery.
Huston TL; Pigalarga R; Osborne MP; Tousimis E
Am J Surg; 2006 Oct; 192(4):509-12. PubMed ID: 16978962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]